Definition
Trypanosoma evansi is a unicellular parasitic protozoan belonging to the genus Trypanosoma in the family Trypanosomatidae. It is the etiological agent of surra, a disease affecting a wide range of domestic and wild mammals, particularly equids, camels, cattle, and buffaloes.
Overview
Trypanosoma evansi is transmitted primarily by biting arthropods, especially hematophagous flies of the genus Tabanidae (horseflies) and Stomoxys (stable flies). Unlike some other trypanosomes, it does not require a cyclical developmental phase within a tsetse fly vector; instead, it is mechanically transmitted through contaminated mouthparts or skin lesions. The parasite circulates in the host’s bloodstream and can invade various tissues, leading to clinical signs such as fever, anemia, edema, weight loss, and in severe cases, death. Surra is endemic in parts of Asia, Africa, the Middle East, and South America, where it poses significant economic losses to livestock industries.
Etymology/Origin
The genus name Trypanosoma derives from the Greek words “τρύπανον” (trýpanon, meaning “borer”) and “σῶμα” (sôma, meaning “body”), referring to the organism’s ability to bore into host cells. The species epithet evansi honors Dr. R. H. Evans, a veterinarian who contributed to early research on the parasite in the early 20th century.
Characteristics
-
Morphology: The bloodstream form (BSF) of T. evansi is an elongated, flagellated cell measuring approximately 20–30 µm in length and 1.5–3 µm in width. It possesses a single kinetoplast—a mitochondrial DNA-containing granule—located adjacent to the basal body of its flagellum. The cell exhibits a distinct free flagellum that aids motility within the host’s circulatory system.
-
Genomics: The genome is diploid and relatively compact, ~25 Mb, encoding a repertoire of variant surface glycoproteins (VSGs) that enable antigenic variation, allowing the parasite to evade the host immune response.
-
Life Cycle: T. evansi undergoes a simple life cycle lacking an obligatory developmental stage in an insect vector. After mechanical transmission, the parasite multiplies as bloodstream trypomastigotes. In some geographic regions, it can undergo limited development in the digestive tract of vectors, but this is not essential for transmission.
-
Pathogenesis: Clinical disease results from parasite-induced hemolysis, immune-mediated anemia, and vascular inflammation. The parasite’s VSG coat undergoes periodic switching, leading to chronic infection and difficulty in achieving sterile immunity.
-
Diagnosis: Laboratory confirmation is achieved by microscopic detection of trypomastigotes in blood smears, concentration techniques (e.g., haematocrit centrifugation), or molecular methods such as PCR targeting species‑specific DNA sequences.
-
Treatment and Control: Chemotherapeutic agents such as suramin, diminazene aceturate, and quinapyramine are used to treat infected animals. Control measures focus on vector management, use of insect repellents, and, where feasible, prophylactic drug administration. No effective vaccine is currently available.
Related Topics
- Surra – the disease caused by T. evansi in mammals.
- Trypanosoma brucei – a closely related species transmitted by tsetse flies, causing African trypanosomiasis (sleeping sickness) in humans.
- Trypanosoma cruzi – the etiological agent of Chagas disease, a distinct trypanosome affecting the Americas.
- Mechanically transmitted parasites – parasites spread by non‑biological transfer via vectors, exemplified by T. evansi.
- Variant Surface Glycoprotein (VSG) antigenic variation – a key immune evasion strategy employed by many trypanosomes.
References: Standard parasitology textbooks, World Organization for Animal Health (OIE) disease fact sheets, peer‑reviewed articles on Trypanosoma evansi biology and epidemiology.